1. Bray, F. et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394-424. [DOI: 10.3322/caac.21492]
2. Cancer Genome Atlas Network. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337. [DOI: 10.1038/nature11252]
3. O’Keefe, S.J. (2016) Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol., 13, 691-706. [DOI: 10.1038/nrgastro.2016.165]
4. Garrett, W.S. (2019) The gut microbiota and colon cancer. Science, 364, 1133-1135. [DOI: 10.1126/science.aaw2367]
5. Gagnière, J. et al. (2016) Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol., 22, 501-518. [DOI: 10.3748/wjg.v22.i2.501]
6. Milani, A. et al. (2017) Carotenoids: biochemistry, pharmacology and treatment. Br. J. Pharmacol., 174, 1290-1324. [DOI: 10.1111/bph.13625]
7. Al-Ishaq, R.K. et al. (2020) Phytochemicals and gastrointestinal cancer: cellular mechanisms and effects to change cancer progression. Biomolecules, 10, E105. [DOI: 10.3390/biom10010105]
8. Wu, S. et al. (2019) Carotenoid intake and circulating carotenoids are inversely associated with the risk of bladder cancer: a dose-response meta-analysis. Adv. Nutr., 11, 630-643. [DOI: 10.1093/advances/nmz120]
9. Djuric, Z. et al. (2018) Colonic mucosal bacteria are associated with inter-individual variability in serum carotenoid concentrations. J. Acad. Nutr. Diet, 118, 606-616.e3. [DOI: 10.1016/j.jand.2017.09.013]
10. Molan, A.L. et al. (2014) Evaluation of the effect of blackcurrant products on gut microbiota and on markers of risk for colon cancer in humans. Phytother. Res., 28, 416-422. [DOI: 10.1002/ptr.5009]
11. Hitoe, S. et al. (2017) Seaweed fucoxanthin supplementation improves obesity parameters in mild obese Japanese subjects. Func. Foods Health Disease, 7, 246-262. [10.31989/ffhd.v7i4.333]
12. Mikami, N. et al. (2017) Reduction of HbA1c levels by fucoxanthin-enriched akamoku oil possibly involves the thrifty allele of uncoupling protein 1 (UCP1): a randomised controlled trial in normal-weight and obese Japanese adults. J. Nutr. Sci., 6, e5. [DOI: 10.1017/jns.2017.1]
13. Abar, L. et al. (2018) Height and body fatness and colorectal cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Eur. J. Nutr., 57, 1701-1720. [DOI: 10.1007/s00394-017-1557-1]
14. Jonasson, J.M. et al. (2014) Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish national diabetes register – register-based cohort study in Sweden. PLos One, 9, e105868. [DOI: 10.1371/journal.pone.0105868]
15. Beppu, F. et al. (2009) Single and repeated oral dose toxicity study of fucoxanthin (Fx), a marine carotenoid, in mice. J. Toxicol. Sci., 34, 501-510. [DOI: 10.2131/jts.34.501]
16. Iio, K. et al. (2011) Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats. Sokuhin Eiseigaku Zasshi, 52, 183-189. [DOI: 10.3358/shokueishi.52.183]
17. Nishino, H. et al. (2009) Cancer prevention by carotenoids. Arch. Biochem. Biophys., 483, 165-168. [DOI: 10.1016/j.abb.2008.09.011]
18. Terasaki, M. et al. (2019) Salivary glycine is a significant predictor for the attenuation of polyp and tumor microenvironment formation by fucoxanthin in AOM/DSS mice. IN VIVO, 33, 365-374. [DOI: 10.21873/invivo.11483]
19. Terasaki, M. et al. (2020) Dietary fucoxanthin induces anoikis in colorectal adenocarcinoma by suppressing integrin signaling in a murine colorectal cancer model. J. Clin. Med., 9, 90-104. [DOI: 10.3390/jcm9010090]
20. Lyu, Y. et al. (2018) Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis. Exp. Biol. Med. (Maywood), 243, 613-620. [DOI: 10.1177/1535370218763760]
21. Molan, A.L. et al. (2010) The ability of blackcurrant extracts to positively modulate key markers of gastrointestinal function in rats. World J. Microbiol. Biotechnol., 26, 1735-1743. [DOI: 10.1007/s11274-010-0352-4]
22. Ashktorab, H. et al. (2019) Saffron: the golden spice with therapeutic properties on digestive diseases. Nutrients, 11, E943. [DOI: 10.3390/nu11050943]
23. Guo, B. et al. (2019) Fucoxanthin modulates cecal and fecal microbiota differently based on diet. Food Funct., 10, 5644-5655. [DOI: 10.1039/c9fo01018a]
24. Xia, H. et al. (2018) Dietary tomato powder inhibits high-fat diet-promoted hepatocellular carcinoma with alteration of gut microbiota in mice lacking carotenoid cleavage enzymes. Cancer Prev. Res. (Phila), 11, 797-810. [DOI: 10.1158/1940-6207.CAPR-18-0188]
25. Suzuki, R. et al. (2006) Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis, 27, 162-169. [DOI: 10.1093/carcin/bgi205]
26. Farhana, L. et al. (2018) Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans. World J. Gastrointest. Pathophysiol., 9, 47-58. [DOI: 10.4291/wjgp.v9.i2.47]
27. Hibberd, A.A. et al. (2017) Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol., 4, e000145. [DOI: 10.1136/bmjgast-2017-000145]
28. Louis, P. et al. (2017) Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol., 19, 29-41. [DOI: 10.1111/1462-2920.13589]
29. Hague, A. et al. (1996) The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?, Proc. Nutr. Soc., 55, 937-943. [DOI: 10.1079/pns19960090]
30. Nordgaard, I. et al. (1996) Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds). Scand. J. Gastroenterol., 31, 1011-1020. [DOI: 10.3109/00365529609003122]
31. Meehan, C.J. et al. (2014) A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol. Evol., 6, 703-713. [DOI: 10.1093/gbe/evu050]
32. Wu, M. et al. (2016) Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota. Oncotarget, 7, 85318-85331. [DOI: 10.18632/oncotarget.13347]
33. Zhang, H. et al. (2019) Canmei formula reduces colitis-associated colorectal carcinogenesis in mice by modulating the composition of gut microbiota. Front. Oncol., 9, 1149. [DOI: 10.3389/fonc.2019.01149]
34. Jiang, F. et al. (2020) Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-κB/IL6-STAT3 signaling pathway. Biomed. Pharmacother., 125, 109982. [DOI: 10.1016/j.biopha.2020.109982]
35. Li, Y. et al. (2012) Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis, 33, 1231-1238. [DOI: 10.1093/carcin/bgs137]
36. Andrews, M.C. et al. (2018) Concepts collide: genomic, immune, and microbial influences on the tumor microenvironment and response to cancer therapy. Front Immunol., 9, 946-961. [DOI: 10.3389/fimmu.2018.00946]
37. Kostic, A.D. et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe, 14, 207-215. [DOI: 10.1016/j.chom.2013.07.007]
38. Wu, X. et al. (2019) Microbiota transplantation: targeting cancer treatment. Cancer Lett., 452, 144-151. [DOI: 10.1016/j.canlet.2019.03.010]
39. Bakken, J.S. et al. (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol., 9, 1044-1049. [DOI: 10.1016/j.cgh.2011.08.014]
40. Wong, S.H. et al. (2017) Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterol., 153, 1621-1633.e6. [DOI: 10.1053/j.gastro.2017.08.022]
41. Li, L. et al. (2019) Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in ApcMin/+ mice. EBioMedicine, 48, 301-315. [DOI: 10.1016/j.ebiom.2019.09.021]
42. Wang, Z. et al. (2019) Prospective role of fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with Treg cells. Front Microbiol., 10, 2498. [DOI: 10.3389/fmicb.2019.02498]
43. Chen, L. et al. (2017) NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat. Immunol., 18, 541-551. [DOI: 10.1038/ni.3690]
論文の公開元へ
